OLN:NYSEOlin Corporation Analysis
Data as of 2026-05-21 - not real-time
$26.31
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Olin Corp. (OLN) is trading at $26.31, just above its 20‑day SMA and below the 200‑day SMA, with the price hovering near a $25.57 support level and a $29.26 resistance. The 30‑day volatility is high at ~48% and beta exceeds 1.3, indicating a volatile, beta‑rich profile, while the RSI of 44 and a bearish MACD suggest limited short‑term upside. Fundamentally, the company posted a Q1 loss of $83 M and a negative operating margin, yet its DCF fair value of $27.65 implies roughly a 10% upside, and a 3.04% dividend yield is attractive despite a payout ratio above 170%.
The balance sheet shows a heavy debt load (DE ratio ~191) and weak ROE, but operating cash flow remains positive and free cash flow is solid. Recent guidance points to improved Q2 EBITDA of $160‑$200 M as pricing improves, and analysts are largely neutral with a “hold” consensus. Overall, the stock presents a mixed picture: modest valuation upside tempered by earnings weakness, high leverage, and an unsustainable dividend policy.
The balance sheet shows a heavy debt load (DE ratio ~191) and weak ROE, but operating cash flow remains positive and free cash flow is solid. Recent guidance points to improved Q2 EBITDA of $160‑$200 M as pricing improves, and analysts are largely neutral with a “hold” consensus. Overall, the stock presents a mixed picture: modest valuation upside tempered by earnings weakness, high leverage, and an unsustainable dividend policy.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Price near technical support with bearish MACD
- High short‑term volatility and beta
- Dividend payout ratio exceeds earnings
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Guidance for higher Q2 EBITDA as pricing improves
- DCF indicates ~10% upside to fair value
- Positive operating cash flow supporting dividend
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Heavy debt burden and negative ROE
- Cyclical chemicals exposure and regulatory headwinds
- Potential for dividend sustainability improvement if earnings turn positive
Key Metrics & Analysis
Financial Health
Revenue Growth-3.70%
Profit Margin-2.75%
P/E Ratio28.2
ROE-9.82%
ROA0.12%
Debt/Equity190.86
P/B Ratio1.6
Op. Cash Flow$511.6M
Free Cash Flow$488.4M
Technical Analysis
TrendBullish
RSI44.0
Support$25.57
Resistance$29.26
MA 20$27.46
MA 50$27.41
MA 200$23.81
MACDBearish
VolumeIncreasing
Fear & Greed Index90.48
Valuation
Fair Value$27.65
Target Price$29.00
Upside/Downside10.22%
GradeFair
TypeValue
Dividend Yield3.04%
Risk Assessment
Beta1.38
Volatility47.81%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.